Capone Mark Christopher received 2,423 derivative securities from Mesa Laboratories on 2026-09-09. The award leaves him with 2,423 derivative securities, meaning the transaction represents about 100.0% of his resulting derivative securities holding. Investors can therefore see the award’s full reported effect on his derivative securities position.
Key Highlights
- Capone Mark Christopher’s resulting derivative securities holding was 2,423.
- The transaction represented about 100.0% of his resulting derivative securities holding.
- Transaction code A classified the event as an award or grant on 9 September 2026.
Capone Mark Christopher, a director of Mesa Laboratories, received 2,423 derivative securities on 9 September 2026. The award left him with 2,423 derivative securities following the transaction.
Director Receives Derivative Securities Award
The reported securities are derivative securities of Mesa Laboratories. The award occurred on 9 September 2026. His post-transaction position was reported at 2,423 derivative securities. The transaction represented about 100.0% of Capone Mark Christopher’s resulting derivative securities holding.
FAQs
Q: What did Capone Mark Christopher receive from Mesa Laboratories?
A: Capone Mark Christopher, a director of Mesa Laboratories, received 2,423 derivative securities on 9 September 2026. Following the transaction, his reported position remained 2,423 derivative securities.
Q: What was Capone Mark Christopher’s resulting holding?
A: Following the Mesa Laboratories insider transaction, Capone Mark Christopher held 2,423 derivative securities. The transaction represented about 100.0% of that resulting holding.
Q: What does transaction code A mean in this Mesa Laboratories transaction?
A: The transaction involved an award of 2,423 derivative securities to Capone Mark Christopher, who was identified as a Mesa Laboratories director. His post-transaction position was reported at 2,423 derivative securities.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.